Imatinib (STI571) plus hydroxyurea: Safety and efficacy in pre-treated, progressive glioblastoma multiforme (GBM) patients (pts) No significant financial relationships to disclose. This is an ASCO ...
Correctly distinguishing between related neurodegenerative diseases remains challenging for clinicians, because reliable markers do not yet exist for many disorders. In the July 22 Neurology, ...
Prognostic value of circulation tumor DNA dosing in patients in neoadjuvant breast neoplasia (GIRO-ctDNA). This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not ...
The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research presented today at the 38th Annual Congress of the European Association of ...
Monitoring treatment response in breast cancer is of great importance and FDG PET has demonstrated its utility in this indication. FDG PET must be performed in patients with advanced disease treated ...
Reston, VA… FDG PET detected recurrent cancer 50% more often than did conventional imaging in persons suffering from thyroid cancer who had indications that their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results